TABLE 1.
Demographic characteristics of CKD and non-CKD.
| CKD (N =1718) | Non-CKD (N =1,718) | ||||
|---|---|---|---|---|---|
| n | % | n | % | p value | |
| Age | 1 | ||||
| 20–64 | 597 | 34.7 | 597 | 34.7 | |
| ≥65 | 1121 | 65.3 | 1121 | 65.3 | |
| Mean ± SD | 68.3 ± 12.2 | 68.3 ± 12.2 | 1 | ||
| Sex | 1 | ||||
| Female | 472 | 27.5 | 472 | 27.5 | |
| Male | 1246 | 72.5 | 1246 | 72.5 | |
| Hypertension | 1480 | 86.1 | 1201 | 69.9 | <0.001 |
| Hyperlipidemia | 952 | 55.4 | 843 | 49.1 | <0.001 |
| Chronic liver disease | 545 | 31.7 | 490 | 28.5 | 0.041 |
| Diabetes | 797 | 46.4 | 560 | 32.6 | <0.001 |
| COPD | 469 | 27.3 | 387 | 22.5 | 0.001 |
| Autoimmune disease | 170 | 9.9 | 163 | 9.5 | 0.686 |
| Cardiovascular disease | 725 | 42.2 | 616 | 35.9 | <0.001 |
| Stroke | 479 | 27.9 | 341 | 19.8 | <0.001 |
| Traditional Chinese medicine | 1049 | 61.1 | 1064 | 61.9 | 0.599 |
| Corticosteroids | 907 | 52.8 | 668 | 38.9 | <0.001 |
| Statin | 825 | 48.0 | 598 | 34.8 | <0.001 |
| NSAIDs | 1634 | 95.1 | 1620 | 94.3 | 0.286 |
| Aspirin | 925 | 53.8 | 752 | 43.8 | <0.001 |
| Gout year | 1 | ||||
| 2000 | 895 | 52.1 | 895 | 52.1 | |
| 2001 | 403 | 23.5 | 403 | 23.5 | |
| 2002 | 296 | 17.2 | 296 | 17.2 | |
| 2003 | 124 | 7.2 | 124 | 7.2 | |
Bold font indicates statistical significance (p < 0.05).
CKD, Chronic kidney disease; COPD, Chronic obstructive pulmonary disease; NSAIDs, Nonsteroidal anti-inflammatory drugs.